Phenominer Database Results (12 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Experiment Notes Record ID Study ID
DA/Ztm percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 10 100.0 % in vivo visual assessment 0.0 0 69722 1162
DA/Ztm post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 10 14.2 d 0.4 1.26 in vivo visual assessment 0.0 0 69790 1162
DA/Ztm maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 10 22.8 % 1.1 3.48 body weighing method 0.0 0 69809 1162
DA/Ztm serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120 days-180 days 10 600.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69769 1162
DA/Ztm maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 12 13.4 % 1.4 4.85 body weighing method 0.0 0 69798 1162
DA/Ztm post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 12 14.5 d 0.5 1.73 in vivo visual assessment 0.0 0 69777 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait male 120 days-200 days 9 100.0 % in vivo visual assessment 0.0 0 69714 1162
DA/Ztm maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass male 120 days-200 days 9 7.5 % 2.1 6.3 body weighing method 0.0 0 69802 1162
DA/Ztm post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait male 120 days-200 days 9 15.2 d 0.2 0.6 in vivo visual assessment 0.0 0 69782 1162
DA/Ztm serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120 days-180 days 12 790.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69756 1162
DA/Ztm serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount male 120 days-180 days 9 590.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69761 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 12 100.0 % in vivo visual assessment 0.0 0 69709 1162